Management of rare adult tumours | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=Mahmut Ozsahin
B01=René-Olivier Mirimanoff
B01=Yazid Belkacemi
Category1=Non-Fiction
Category=MJCL
COP=France
Delivery_Delivery within 10-20 working days
Language_English
PA=Available
Price_€100 and above
PS=Active
softlaunch

Management of rare adult tumours

English

Why a book dedicated to rare cancer management?

Given the large variety of rare cancers,they take up a significant part of our daily practice. Therefore, we owe it to our patients with rare tumours that we use the knowledge gained in the treatment of the more common cancers to provide them with a better future. This knowledge comes from recent developments in molecular diagnostics, systemic treatments with new drugs and targeted therapies together with advanced technologies in the areas of radiology and radiation therapy. Our authors have analysed the literature and recommend treatments for rare cancers based on results from past studies. We hope that this book will be an aid to those treating rare cancer cases about which, up to now, little has been published, and will reassure our patients that they have not been forgotten.

See more
Current price €183.34
Original price €192.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=Mahmut OzsahinB01=René-Olivier MirimanoffB01=Yazid BelkacemiCategory1=Non-FictionCategory=MJCLCOP=FranceDelivery_Delivery within 10-20 working daysLanguage_EnglishPA=AvailablePrice_€100 and abovePS=Activesoftlaunch
Delivery/Collection within 10-20 working days
Product Details
  • Publication Date: 22 Jan 2010
  • Publisher: Springer Editions
  • Publication City/Country: France
  • Language: English
  • ISBN13: 9782287922459

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept